SUMMARY Twenty-nine patients with primary sclerosing cholangitis were reviewed. Males predominated (2:1). Seventy-six per cent presented with cholestasis and cholangitis, 17 % with cirrhosis and portal hypertension, and 7% were asymptomatic, presenting with a raised serum alkaline phosphatase. The serum immunoglobulin IgM concentration was raised in 45 % of the patients, but no patient had serum mitochondrial antibody present. Seventy-two per cent had ulcerative proctocolitis. There was no relationship between either duration or severity of ulcerative proctocolitis and the development of primary sclerosing cholangitis. Four patients were not benefited by colectomy. None of the patients had Crohn's disease. The prognosis was variable. Corticosteroids and azathioprine were ineffective. Eleven patients (38 %) had died with a mean survival time of seven years from diagnosis. Three patients with ulcerative proctocolitis developed bile duct carcinoma. The cholangiograms and liver biopsies were reported without reference to clinical information together with 41 patients with other biliary diseases. Cholangiography was diagnostic in 18/22 (82 %). Hepatic histology was diagnostic in 8/22 (36 %). Ten showed features of large bile duct disease and three were misdiagnosed as primary biliary cirrhosis. Reduced numbers of bile ducts, ductular proliferation, portal inflammation, and substantial copper deposition, in combination with piecemeal necrosis, are commonly seen in primary sclerosing cholangitis and indicate the need for cholangiography.
ances have been assessed and reviewed by histopathologists and radiologists without knowledge of the diagnosis and in conjunction with 41 patients with other biliary tract diseases, also reviewed blind.
Methods

PATIENTS
Twenty-nine patients with PSC were studied. The diagnosis was established by a clinical presentation without previous biliary surgery, and by the demonstration of generalised beading and stenosis of the biliary system. Bile duct carcinoma was excluded in 18 patients by a laparotomy and bile duct biopsy. The remaining 11 patients have been followed up for at least three years (mean five years).
At presentation, liver function tests, serum immunoglobulin levels, and autoantibodies were estimated.
The control group consisted of secondary sclerosing cholangitis5 (five patients); primary biliary cirrhosis (10 patients); benign and malignant bile 870 duct strictures (eight patients); cirrhosis (six patients); ulcerative proctocolitis without PSC (eight patients), and miscellaneous cholestatic liver disease (four patients).
The diagnosis of secondary sclerosing cholangitis was based on the demonstration of stricturing and dilatation of the biliary system with a history of gallstones and/or bile duct surgery.
CHOLANGIOGRAPHY
Cholangiograms from 22 patients were examined by two experienced observers who were unaware of the diagnosis. Fourteen of the 22 patients with PSC had endoscopic retrograde cholangiography, seven percutaneous transhepatic cholangiography, and one T-tube cholangiography.
The common bile duct, right and left hepatic ducts, and intrahepatic ducts were assessed for stricturing and dilatation. The intrahepatic bile ducts were also assessed for the regularity of their course and calibre. Filling of the gall bladder and the presence of gall stones were noted.
The diagnosis of PSC was based on the demonstration ofmultiple stricturing and dilatation ofthe biliary tree.24f Cirrhosis was suspected whenever pruning (thinning and decreased arborisation) and tortuosity of the intrahepatic bile ducts were seen. Jaundice  21  72  Pruritus  20  69  Weight loss  23  79  Right upper quadrant pain  21  72  Acute cholangitis  13  45  Bleeding oesophageal varices  4  14  Malaise  1  3  Asymptomatic  2  7  Total  29 The liver histology from all 29 patients was then reviewed to assess other diagnostic features of PSC.
Results CLINICAL FEATURES (Table 1) The 20 males and nine females (ratio 2:1) were aged at presentation between 10-68 years. Nineteen (66%) patients presented between the ages of 25 and 40 years and the mean age was 36 years.
The majority of patients presented with weight loss, pain in the right upper quadrant, pruritus and acute cholangitis, characterised by intermittent fever, rigors, and jaundice.
Five (17%) presented with cirrhosis and portal hypertension; four of these had bled from oesophageal varices, and one had malaise and hepatosplenomegaly. None of these five patients had had cholestasis or cholangitis, three had been treated as cryptogenic cirrhosis for two, six and seven years before the diagnosis of PSC was established. Two patients were asymptomatic and were diagnosed by persistently raised serum alkaline phosphatase levels (Fig. 1) . Seventeen (59%) developed persistent hyperbilirubinaemia, but three (10%) had never been jaundiced. (Table 2) The liver function tests were usually cholestatic. Serum alkaline phosphatase level was more than three times normal in 22/29 (76%) (Fig. 2) . A peripheral blood eosinophilia of more than 0.4 X 109/l circulating eosinophils was observed in only two patients.
LABORATORY INVESTIGATIONS
Increased serum IgM concentration was seen in 45% of 20 patients tested (Fig. 2) formed. Inflammatory bowel disease was excluded as far as possible in the other eight patients by a normal barium enema and rectal biopsy. The course of the colitis was generally mild with prolonged remissions. Seven had never complained of rectal bleeding and only suffered from episodic diarrhoea. Ulcerative prococolitis usually developed before PSC (mean of eight years-range three months to 31 years). However, in four patients the PSC appeared to precede the onset of ulcerative proctocolitis by one to three years, and in another seven patients the diagnosis of PSC was made within four years of the first symptom of colitis.
There was no relationship between the exacerbation of acute colitis and acute ascending cholangitis. The outcome of PSC seemed unrelated to the severity and clinical course of the colitis. Despite the high prevalence of total proctocolitis (71 %) only four patients had had a colectomy performed. In two of the four the first symptom of PSC appeared two years after colectomy and in the other two patients, colectomy did not result in any clinical or biochemical improvement.
One patient also suffered from ankylosing spondylitis (HLA type B27 positive). Other medical conditions occurring were thyrotoxicosis (two patients), vitiligo, renal tubular acidosis, and rheumatoid arthritis (one patient each). Riedel's thyroiditis without retroperitoneal fibrosis was confirmed at necropsy in one patient without colitis.
No patients in the series had Crohn's disease. Strictures of the extrahepatic biliary tree were present in 20/22 patients (91%). The calibre of the intrahepatic ducts was irregular in all 20 patients in whom the intrahepatic ducts were opacified. Six patients with PSC also had the radiological appearance of cirrhosis, in five confirmed by liver biopsy.
Three patients had no abnormalities of the intrahepatic bile ducts, but multiple strictures of the extrahepatic biliary tree.
The appearances of secondary sclerosing cholangitis were identical with those of PSC.
Three of the eight patients with ulcerative procto- Of the eight patients with ulcerative proctocolitis in the control group who did not have cholangiographic abnormalities suggestive of PBC, one was diagnosed as sclerosing cholangitis, one as PBC, and six were reported as having non-specific biliary disease. Sclerosing cholangitis was not diagnosed histologically in any of the other patients in the original mixed group of 64 patients. All 10 patients with PBC were correctly identified.
As the diagnostic accuracy was low using conventional criteria, the liver histology from all 29 patients with PSC was then further reviewed (Tables 3 and 4) so that specific diagnostic features could be identified. In every biopsy an inflammatory reaction in the portal tracts was seen (Fig. 3) . The inflammatory infiltrate was composed of lymphocytes, plasma cells and histiocytes, and polymorphonuclear leucocytes in association with proliferating bile ductules. Lymphoid aggregates were observed in 11 patients (30`) and granulomas were seen in three patients (1010).
The number of interlobular bile ducts in relation to the number of small arteries was normal (1:12) in 12 patients (41`O) and reduced in 10 (340) (1:5-10). In the remaining seven patients (24°o) no bile ducts were seen (Fig. 3) . Morphological changes in the bile ducts were observed in eight patients (280o). These consisted of flattened epithelial cells, vacuolation of epithelial cells, and inflammatory infiltration of the bile duct wall. Periductal fibrosis was seen in 11 patients (38`o). Bile ductular proliferation was found in the majority of patients (86°' ) and was frequently (76°0) associated with polymorphonuclear leucocytes (Fig. 4) .
In the periportal areas piecemeal necrosis was noted in 19 patients (66O') (Fig. 3) . This was of moderate severity in 11 (380°); however, bridging hepatic necrosis was not observed. There was no correlation with serum autoantibodies. (Fig. 5) ; in 11 of these there was no morphological evidence of cholestasis.
Discussion
The male predominance in our patients has been shown previously4 but does not reflect the sex incidence of ulcerative proctocolitis which has a slight female predominance.10
The majority of patients, as in previous series, presented between the ages of 25 and 45 years.451 However, the range was wide, and the youngest patient was a girl aged 10 years.
It is widely believed that PSC always presents with cholangitis and cholestasis.12 However, while the majority of our patients did present in this way, 17% had never been jaundiced and presented with either cirrhosis and portal hypertension or were asymptomatic, although all had a raised serum alkaline phosphatase. Three patients had been diagnosed as 'cryptogenic' cirrhosis for some years before cholangiography was performed and this study has shown for the first time that a number of patients with 'cryptogenic cirrhosis' may have cirrhosis secondary to PSC. We believe that cholangiography is indicated in patients with 'cryptogenic cirrhosis' in whom the serum alkaline phosphatase is persistently raised.
Asymptomatic PSC has not previously been recognised. The early diagnosis of PSC in these patients may be explained by the advent of endoscopic retrograde and chiba needle cholangiography, as in the past laparotomy was needed to confirm the diagnosis.
Although serum immunoglobulins in PSC have been reported to be normal,6 in this study a raised immunoglobulin IgM was found. The levels of IgM observed were greater than those found in longstanding bile duct obstruction,13 but correspond more closely to those observed in primary biliary cirrhosis.13 The presence in the serum of antinuclear factor and smooth muscle antibody found in this study has not been previously observed. However, the antibody titres were low and have no diagnostic significance, as low titres of these autoantibodies are known to result from any parenchymal liver damage.14 PSC is closely associated with ulcerative proctocolitis, and, in this study, ulcerative proctocolitis was found in 72% of our patients, more than previously reported.46 The higher prevalence of ulcerative proctocolitis in our series may reflect both an increasing awareness of this association and improved cholangiographic techniques.
Although total involvement of the colon and rectum was frequently observed, the colitis was usually symptomatically mild, often with no rectal bleeding. These findings were in contrast with the observation of Warren et a14 that the ulcerative proctocolitis was moderately severe.
The aetiology of PSC is unknown. It has been suggested that it may be related in ulcerative proctocolitis to a chronic low-grade infection of the biliary tree spreading via the portal circulation from the diseased colon.4612 This appears unlikely, as in our patients PSC could be diagnosed before the ulcerative proctocolitis and did not improve either after remission of colitis or after colectomy. The association with other diseases such as Riedel's strumal" and retroperitoneal fibrosis also needs to be explained.
None of these patients in this large study had Crohn's disease. Only two cases of the association of PSC and Crohn's have been reported'6 We feel that laparotomy should not be performed routinely to confirm the diagnosis of PSC but should be reserved for the minority of patients with complete obstruction of the main bile duct to exclude bile duct carcinoma. Surgery may be also required to relieve bile duct obstruction and to remove biliary sludge and stones above strictures.
Hepatic histology is not usually diagnostic in PSC using standard criteria, although some form of biliary disease can usually be identified, indicating the need for cholangiography.
In view of the low diagnostic accuracy, an additional more detailed histological study was performed. Two-thirds of the patients showed piecemeal necrosis suggesting a possible diagnosis of chronic active hepatitis. This lesion is usually defined in terms of chronic inflammation, fibrosis, and piecemeal necrosis. However, piecemeal necrosis is also found in other conditions, including PBC. In our patients it was not thought to indicate concurrent chronic active hepatitis, as there was no relationship between serum autoantibodies and piecemeal necrosis, the titres of smooth muscle antibody were low or absent, and immunoglobulin IgG was not raised. We believe that in our patients the necrosis represented one of the many different histological features of PSC.
The majority of patients showed marked diminution of small bile ducts in the portal tracts, placing PSC, like PBC, in the group of diseases characterised by bile duct destruction. However, periductal fibrosis, a characteristic lesion of the bile ducts in PSC,8 is not a constant feature and was seen in only one-third of our patients.
Accumulation of copper and copper-associated protein are features of any chronic cholestasis. However, the degree and frequency of copper accumulation were striking and similar to those found in late stage PBC.2324 Increased copper and copper-associated protein were seen in the absence of bile pigment deposition and may provide the only histological evidence of underlying biliary disease.
The relationship between PSC and 'pericholangitis' is not clear. Many of the present liver biopsies could, on histological grounds, be classified as 'pericholangitis'.26 Cholangiography was not performed on the patients originally described26 and we feel that it is doubtful whether 'pericholangitis' exists as a separate clinical entity from PSC. A recent report has shown that six out of eight patients with 'pericholangitis' and ulcerative proctocolitis had abnormalities of the bile ducts on ERCP.27 We believe that cholangiography should be performed in patients with ulcerative proctocolitis and persistently abnormal liver function tests in order to exclude PSC.
It is apparent from this and other studies,28 that PSC may be confused with PBC. The clinical and histological features can be similar and the serum IgM may be high in both diseases. However, in our patients with PSC, the serum mitochondrial antibody was always negative. We feel that cholangiography should be carried out in patients with suspected PBC and a negative mitochondrial antibody.
This study has shown that cholangiography is effective in the diagnosis of PSC and we believe that laparotomy should be reserved for patients with complete obstruction of the main bile duct.
We have also shown that the clinical presentation and prognosis of PSC is more variable than previously recognised. PSC should be considered in patients with ulcerative proctocolitis and abnormal liver function tests, irrespective of symptoms; 'cryptogenic' cirrhosis with a high serum alkaline phosphatase; and mitochondrial antibody negative 'primary biliary cirrhosis '. 
